Literature DB >> 19844246

Thyroid gland: Antithyroid therapy--best choice of drug and dose.

Jayne A Franklyn.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19844246     DOI: 10.1038/nrendo.2009.201

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  9 in total

Review 1.  Antithyroid drugs.

Authors:  David S Cooper
Journal:  N Engl J Med       Date:  2005-03-03       Impact factor: 91.245

2.  Putting propylthiouracil in perspective.

Authors:  David S Cooper; Scott A Rivkees
Journal:  J Clin Endocrinol Metab       Date:  2009-04-28       Impact factor: 5.958

3.  The Role of Propylthiouracil in the Management of Graves' Disease in Adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration.

Authors:  Rebecca S Bahn; Henry S Burch; David S Cooper; Jeffrey R Garber; Carol M Greenlee; Irwin L Klein; Peter Laurberg; I Ross McDougall; Scott A Rivkees; Douglas Ross; Julie Ann Sosa; Marius N Stan
Journal:  Thyroid       Date:  2009-07       Impact factor: 6.568

Review 4.  A systematic review of drug therapy for Graves' hyperthyroidism.

Authors:  Prakash Abraham; Alison Avenell; Christine M Park; Wendy A Watson; John S Bevan
Journal:  Eur J Endocrinol       Date:  2005-10       Impact factor: 6.664

5.  The incidence and clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism: a single-center retrospective study.

Authors:  H J Kim; B H Kim; Y S Han; I Yang; K J Kim; S H Dong; H J Kim; Y W Chang; J I Lee; R Chang
Journal:  Am J Gastroenterol       Date:  2001-01       Impact factor: 10.864

6.  Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease.

Authors:  Hirotoshi Nakamura; Jaeduk Yoshimura Noh; Koichi Itoh; Shuji Fukata; Akira Miyauchi; Noboru Hamada
Journal:  J Clin Endocrinol Metab       Date:  2007-03-27       Impact factor: 5.958

7.  Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK.

Authors:  Simon H S Pearce
Journal:  Clin Endocrinol (Oxf)       Date:  2004-11       Impact factor: 3.478

8.  Methimazole-induced agranulocytosis in patients with Graves' disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily.

Authors:  Kazuna Takata; Sumihisa Kubota; Shuji Fukata; Takumi Kudo; Eijun Nishihara; Mitsuru Ito; Nobuyuki Amino; Akira Miyauchi
Journal:  Thyroid       Date:  2009-06       Impact factor: 6.568

9.  Antithyroid drug-induced agranulocytosis: special reference to normal white blood cell count agranulocytosis.

Authors:  Junichi Tajiri; Shiro Noguchi
Journal:  Thyroid       Date:  2004-06       Impact factor: 6.568

  9 in total
  3 in total

1.  Cytoprotective Effects of Organosulfur Compounds against Methimazole Induced Toxicity in Isolated Rat Hepatocytes.

Authors:  Reza Heidari; Hossein Babaei; Mohammad Ali Eghbal
Journal:  Adv Pharm Bull       Date:  2013-02-07

Review 2.  Factors affecting drug-induced liver injury: antithyroid drugs as instances.

Authors:  Reza Heidari; Hossein Niknahad; Akram Jamshidzadeh; Narges Abdoli
Journal:  Clin Mol Hepatol       Date:  2014-09-25

3.  Hyperthyroidism in the personalized medicine era: the rise of mathematical optimization.

Authors:  Fanwen Meng; Enlin Li; Paul Michael Yen; Melvin Khee Shing Leow
Journal:  J R Soc Interface       Date:  2019-06-26       Impact factor: 4.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.